CHOC’s Emergency Department and mobile clinic tests digital screening tool to quickly identify social needs of patient families and provide resources.
Sepsis study could lead to groundbreaking targeted immunomodulatory treatment
CHOC participates in exciting study of sepsis, aimed to design personalized treatment and therapies to address patients’ immune profiles.
New study shows promise of AI in helping to diagnose and treat rare autoimmune disorder
CHOC Research studies the use of artificial intelligence tools in detecting juvenile dermatomyositis (JDM), a rare autoimmune disorder.
CHOC IRB members serve critical role of protecting the rights of human research subjects
Meet members of CHOC’s institutional review boards (IRB), who protect the rights and welfare of pediatric patients recruited to participate in studies.
UCI AI innovation challenge winners include students involved in pediatric research at CHOC
Students involved in CHOC’s Research Institute were on winning teams with projects utilizing AI to improve patient outcomes.
FDA approval grows use of growth therapy for children with achondroplasia
The most common type of dwarfism, achondroplasia can now be treated with Voxzogo starting at birth, maximizing children’s growth potential.
